WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk
Functional aspects
[8] For compounded HRT, endometrial safety monitoring applies to any patient with a uterus receiving estrogen without adequate progestogen
New Insights into TGF-/Smad Signaling in Tissue Fibrosis
Wegovy and Zepbound are extremely effective for weight loss
doi:10.1136/bmjopen-2013-003207 1 Hope VD, Harris R, McVeigh J, Cullen KJ, Smith J, Parry JV, DeAngelis D, & Ncube F